Founding Publication

Take Part in BPI 2013

• Attend - Save $400 by June 28
• Present a Poster
• Sponsor/Exhibit

"A great opportunity for industrial networking." - Joerg Von Hagen, R&D Manager, Merck

The Evolution of BioProcess International

See the industry advacements discussed at BPI over the past ten years.

"This conference is both a great opportunity for 'newbies' in the field to get a great perspective as well as 'veterans' to have a forum for sharing the latest advances and learnings." - Elizabeth C. Dodson, BD Biosciences

"BPI is a great opportunity to meet leaders, and innovators in this industry." - Holzer Margit, VP R&D and Technology, Novasep

"This conference is always a great opportunity to get a very comprehensive overview on new trends in biologics process development, manufacturing aspects and new trends in the biologics business." - Wolfgang Noe, Ph.D., Vice President, Bioprocess Development, Biogen Idec

Networking

Continue to Connect and Communicate with your Peers All Year Round

Join "BioProcessing Professionals"

Follow us on Twitter

Connect on Facebook

RSS News Feed

2012 Event Wrap-Up

Over 1,500 members of the bioprocessing industry gathered in Providence, RI for an interactive week of learning, networking and collaboration.

» Read more of the 2012 Wrap-Up

Where Industry Connects to Share Technical, Scientific and Strategic Solutions across All Phases of Bioprocess Development

Now celebrating its 10th Anniversary, BPI attracts experts from all bioprocessing and biomanufacturing disciplines and all levels, from research scientist to group leader to senior level executive who share and discuss their challenges in an interactive, learning environment.

PREPARE your bioprocessing operations for...

• More complex/diverse molecules
• Improved efficiency, speed and quality
• The emergence of biosimilars
• Managing many compounds at onceNew flexible production options
• Achieving disruptive process improvements
• Leveraging technologies to streamline development
• Innovation at process interfaces

Perspectives from Visionary Keynote Speakers

Producing High Quality, Low Cost Biotherapeutics in the Century of Biology

James Thomas, Ph.D. / Amgen, Inc. Vice President, Process and Product Development and WA Site Head

Transforming the Development of Biotechnology Drugs for the 21st Century: A CEO's Perspective from a Small Biotech Company

Abbie Celniker, Ph.D. / Eleven Biotherapeutics CEO

Biologics Manufacturing in a Rapidly Changing Environment

Peter Moesta, Ph.D. / Bristol-Myers Squibb Senior Vice President, Biologics Manufacturing & Process Development

Eliminating Interfaces: Process Development Lessons from Aggressive Platform Development

Lars Pampel, Ph.D. / Novartis Pharma AG, Switzerland Group Head, Early Phase Process Development

A Systems Approach to Managing Biomanufacturing Complexity - Genzyme's Allston Plant Case Study

Sandra Poole / Genzyme Senior Vice President Biologics Operations and Allston Site Head

What's New This Year?

• BPI Connect - The Partnering Tool and Conference App to Enhance Your Experience Before, During and After the Event
• More presentations and case studies on a wider array of molecules beyond mAbs to help you meet the challenges of diversifying product portfolios
• New four-day format with exhibition and poster sessions open on all main conference days to facilitate great cross-fertilization of ideas you will learn in conference sessions
• Symposia, session and interactive discussion on Achieving Supply Chain Transparency to discuss best practices, what a fully implemented process looks like, and strategies to save time and money
• A town hall forum on Harmonization of Single Use Systems: Extractables & Leachables where representatives of BPSA, ASTM, ASME BPE, PDA, BPOG and ISPE will discuss best practices in the field
• Point-counterpoint discussion on Capture Options in Antibody Purification to explore current limitations, emerging options, and obstacles to change